Sabatakaki A, Daifotis Z, Karayannacos P, Danou K, Kaniaris P
Hôpital Général Laikon, Faculté de Médecine, Université d'Athènes, Grèce.
Cah Anesthesiol. 1992;40(5):317-20.
H2 receptor antagonists are often used to reduce gastric acidity prior to general or regional anaesthesias. However cimetidine and ranitidine have been found to increase plasma levels of local anaesthetics such as lidocaine. This study aimed to compare famotidine--another H2 receptor antagonist--with cimetidine in this respect. 33 male patients 70 years old or more, scheduled for surgery under spinal anaesthesia and randomized into 3 groups, received either diazepam 0.15 mg.kg-1 and famotidine 20 mg (group A) or diazepam and cimetidine 200 mg (group B) or diazepam only (group C) on the previous night and 90 minutes before spinal anaesthesia by hyperbaric lidocaine 5%, 3 ml. Arterial blood samples were taken 3 minutes after spinal injection then every 15 minutes unto 90 minutes after the first sampling. Lidocaine plasma levels were measured by fluorescence polarization immunoassay and the results were statistically analyzed. In famotidine group lidocaine levels were intermediate between B and C groups levels, and the increase was of lesser duration than in B group. Elimination mechanism of lidocaine with and without H2 inhibitor is briefly discussed. Therefore famotidine would appear to be more convenient than other H2 receptor inhibitors whenever antacid protective effects are sought after prior to regional anaesthesia.
H2受体拮抗剂常用于在全身麻醉或区域麻醉前降低胃酸度。然而,已发现西咪替丁和雷尼替丁会增加利多卡因等局部麻醉药的血浆浓度。本研究旨在比较另一种H2受体拮抗剂法莫替丁与西咪替丁在这方面的差异。33名70岁及以上的男性患者计划接受脊髓麻醉下的手术,并随机分为3组,在前一晚和脊髓麻醉前90分钟分别接受地西泮0.15mg·kg-1和法莫替丁20mg(A组)、地西泮和西咪替丁200mg(B组)或仅接受地西泮(C组),通过5%的高压利多卡因3ml进行脊髓麻醉。脊髓注射后3分钟采集动脉血样本,然后在首次采样后每15分钟采集一次,直至90分钟。通过荧光偏振免疫测定法测量利多卡因血浆浓度,并对结果进行统计学分析。在法莫替丁组中,利多卡因水平介于B组和C组之间,且升高持续时间比B组短。简要讨论了有无H2抑制剂时利多卡因的消除机制。因此,在区域麻醉前寻求抗酸保护作用时,法莫替丁似乎比其他H2受体抑制剂更方便。